SE8204561L - Sett att behandla proliferativa hudsjukdomar med anvendning av vissa 6,8-substituerade ribofuransylpurin-3, 5-cykliska fosfater - Google Patents

Sett att behandla proliferativa hudsjukdomar med anvendning av vissa 6,8-substituerade ribofuransylpurin-3, 5-cykliska fosfater

Info

Publication number
SE8204561L
SE8204561L SE8204561A SE8204561A SE8204561L SE 8204561 L SE8204561 L SE 8204561L SE 8204561 A SE8204561 A SE 8204561A SE 8204561 A SE8204561 A SE 8204561A SE 8204561 L SE8204561 L SE 8204561L
Authority
SE
Sweden
Prior art keywords
carbon atoms
inclusive
hydrogen
group
alkyl
Prior art date
Application number
SE8204561A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8204561D0 (sv
Inventor
J P Miller
W W Zmolek
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of SE8204561D0 publication Critical patent/SE8204561D0/xx
Publication of SE8204561L publication Critical patent/SE8204561L/

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8204561A 1981-08-05 1982-08-03 Sett att behandla proliferativa hudsjukdomar med anvendning av vissa 6,8-substituerade ribofuransylpurin-3, 5-cykliska fosfater SE8204561L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/290,223 US4369181A (en) 1981-08-05 1981-08-05 Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates

Publications (2)

Publication Number Publication Date
SE8204561D0 SE8204561D0 (sv) 1982-08-03
SE8204561L true SE8204561L (sv) 1983-02-06

Family

ID=23115047

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204561A SE8204561L (sv) 1981-08-05 1982-08-03 Sett att behandla proliferativa hudsjukdomar med anvendning av vissa 6,8-substituerade ribofuransylpurin-3, 5-cykliska fosfater

Country Status (7)

Country Link
US (1) US4369181A (cs)
JP (1) JPS5826818A (cs)
CA (1) CA1198678A (cs)
DE (1) DE3228060A1 (cs)
FR (1) FR2510889B1 (cs)
GB (1) GB2103086A (cs)
SE (1) SE8204561L (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202321B (it) * 1985-06-06 1989-02-02 Uni Degli Studi Di Parmo Nucleotidi ciclici fluorescenti biologicamente attivi
DE3786714T2 (de) * 1986-06-16 1994-03-10 Daiichi Seiyaku Co Therapeutisches Mittel für Hautgeschwüre.
JPS6331838A (ja) * 1986-07-25 1988-02-10 Oi Seisakusho Co Ltd シ−トスライド装置
US5376643A (en) * 1986-09-18 1994-12-27 Lion Corporation Composition for application to hair
WO1989005647A1 (en) * 1987-12-21 1989-06-29 Nucleic Acid Research Institute Treatment of malignant tumors with 8-aminoadenosine 3',5'-cyclic phosphate and combinations of 8-aminoadenosine 3',5'-cyclic phosphate and 8-chloroadenosine 3',5'-cyclic phosphate
AU3760489A (en) * 1988-05-23 1989-12-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Derivatives of cyclic amp as treatment for cancer
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
CA2052193A1 (en) * 1990-09-28 1992-03-29 Norio Takasugi Topical powder composition containing cyclic amp derivative
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
AU657033B2 (en) * 1992-01-27 1995-02-23 Daiichi Pharmaceutical Co., Ltd. Cyclic AMP derivative-containing ointment
JPH09506333A (ja) * 1993-09-17 1997-06-24 ギリアード サイエンシーズ,インコーポレイテッド 治療化合物の投薬方法
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5747474A (en) * 1996-07-29 1998-05-05 Immune Modulation, Inc. Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
CZ306984B6 (cs) * 2014-12-15 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 6,8-Disubstituované-9-(heterocyklyl)puriny, přípravky obsahující tyto deriváty a jejich použití v kosmetických a medicínských aplikacích

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211770A (en) * 1973-01-16 1980-07-08 The Upjohn Company Treatment of psoriasis intralesionally with N6 -2'-O-dibutyryl cyclic AMP
US4058659A (en) * 1974-05-31 1977-11-15 Icn Pharmaceuticals, Inc. 6,8-Disubstituted purine derivatives of 9-β-D-ribofuranosyl 3',5'-cyclic phosphate
GB1504891A (en) * 1974-05-31 1978-03-22 Icn Pharmaceuticals Purine nucleotides
US4048307A (en) * 1974-12-26 1977-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Cyclic adenosine monophosphate 8-substituted derivatives
FR2358155A1 (fr) * 1976-07-15 1978-02-10 Lapinet Eugene Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
US4235887A (en) * 1977-04-13 1980-11-25 The Upjohn Company Process for therapeutic treatment

Also Published As

Publication number Publication date
US4369181B1 (cs) 1985-07-16
FR2510889B1 (fr) 1986-02-28
SE8204561D0 (sv) 1982-08-03
DE3228060A1 (de) 1983-02-24
US4369181A (en) 1983-01-18
JPS5826818A (ja) 1983-02-17
CA1198678A (en) 1985-12-31
FR2510889A1 (fr) 1983-02-11
GB2103086A (en) 1983-02-16

Similar Documents

Publication Publication Date Title
SE8204561L (sv) Sett att behandla proliferativa hudsjukdomar med anvendning av vissa 6,8-substituerade ribofuransylpurin-3, 5-cykliska fosfater
PT83843B (pt) Processo para a preparacao de promedicamentos de rapamicina
ES527954A1 (es) Un procedimiento para preparar isoxazoles
DK385579A (da) Fremgangsmaade til fremstilling af 9-(hydroxyalkyl) puriner
ES8405274A1 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
ES480880A1 (es) Un procedimiento de preparacion de tetrazinas sustituidas.
DK330783D0 (da) Fremgangsmade til fremstilling af furanonderivater
ES2054859T3 (es) 11 beta-fenil-4,9,15-estratrienos, su preparacion y preparados farmaceuticos que los contienen.
SE8604950L (sv) Demensforbettrande och terapeutiska medel
ES470746A1 (es) Un procedimiento para preparar derivados de dihidropirano 6-sustituido
DE3476847D1 (en) A remedial or prophylactic agent for the treatment of seizures
NO158256C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trisubstituerte pyrimido(5,4-d)pyrimidiner.
SE8305157D0 (sv) Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma
DK294883D0 (da) Fremgangsmade til fremstilling af alfa-alkylpolyolefincarboxylsyrer
ES8704933A1 (es) Procedimiento para la obtencion de nuevos compuestos de piridazinio
BR8005047A (pt) Composicoes para regular o crescimento vegetal
ES475120A1 (es) Un procedimiento para la preparacion de imidazo (1,5-b)piri-dazinas.
IE812975L (en) Use of azolylglycols as plant growth regulants
SE7902867L (sv) Antikomplementera medel
DE3172309D1 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
ES8104232A1 (es) Procedimiento para preparar nuevos compuestos de quinolona
ATE6063T1 (de) Cycloalkano-thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ZA801343B (en) Oxadiazolylmethylthiol phosphates
IE42942L (en) Herbicidal triazine-diones
DE3060406D1 (en) Antimycotic agent, process for its preparation

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8204561-8

Effective date: 19921113